Background. The mechanism of metabolic regulation of coronary vascular tone is still unclear. Therefore, we examined the role of vascular smooth muscle K+ATP channels in regulating coronary blood flow under resting conditions, during increments in myocardial metabolic demand produced by treadmill exercise, and in response to a brief ischemic stimulus.
In the normal heart, coronary blood flow is precisely regulated in response to changing myocardial needs to maintain a consistently high level of oxygen extraction by the myocardium.1 This close coupling between myocardial demands and coronary blood flow is especially apparent during the coronary vasodilation that occurs with exercise. The linkage of coronary vasomotor tone to myocardial metabolic demands has been suggested to depend on messengers released from the myocardium or vascular endothelium. 23 However, specific blockers of known endogenous vasodilators such as adenosine, prostacyclin, or nitric oxide have not been found to impair the normal increases in coronary blood flow that occur during exercise. [4] [5] [6] Recent evidence indicates that hyperpolarization of coronary vascular smooth muscle caused by opening of K+ATP channels contributes to regulation of coronary vasomotor tone.7-9 Thus, agents that inhibit K+ATP channel opening have been reported to decrease basal levels of coronary blood flow and impair coronary vasodilation Then, the intracoronary infusion of glybenclamide was restarted at a rate of 1.5 mL/min, equivalent to 50 ,g* kg.* min-', and the exercise protocol was repeated. Blood specimens were maintained in iced syringes until the conclusion of each exercise protocol. Measurements of Po2, Pco2, and pH then were immediately performed with an Instrumentation Laboratory model 113 blood gas analyzer (Lexington, Mass). Hemoglobin content (g/dL) was determined with the cyanomethemoglobin method. Hemoglobin saturation was estimated from the blood Po2, pH, and temperature using the oxygen dissociation curve for canine blood.14 Blood oxygen content (vol%) was computed as (hemoglobin x 1.34x %O2saturation)+(0.0031 xPo2). Oxygen consumption in the region of myocardium perfused by the left anterior descending coronary artery was calculated as the product of blood flow measured with the Doppler flow probe and the difference in oxygen content between aortic and coronary venous blood.
Effect of vehicle. In an additional five animals, the effects of intracoronary infusion of glybenclamide vehicle (0.3 and 1.5 mL/min) on exercise-induced changes in coronary blood flow and regional systolic wall thickening were studied.
Mechanism ofdepressed systolic function during glybenclamide. To determine whether glybenclamide caused a primary decrease in systolic wall thickening or whether decreased systolic function resulted from the decreased coronary blood flow that it produced, we examined the response of systolic wall thickening when coronary blood flow was increased with nitroprusside in three dogs. Animals were studied while they were standing quietly in a sling. Hemodynamic measurements, coronary blood flow, and systolic wall thickening were obtained during control conditions and during intracoronary infusion of nitroprusside (1.5 ug -kg-'. minm ; infusion rate, 0.15 mL/min). Measurements were then repeated during intracoronary infusion of glybencla- (Table 2) . Peak blood flow rates during reactive hyperemia following 5-, 10-, and 20-second occlusions were attenuated by glybenclamide in a dose-dependent manner. The absolute reduction in peak reactive hyperemia blood flow produced by glybenclamide was independent of the duration of the coronary artery occlusion (Table 2, Fig 3) . Fig 3) .
Exercise
The hemodynamic responses to increasing levels of exercise are shown in Table 1 . Heart rate increased from 129±12 at rest to 244±7 beats per minute at peak exercise (P<.05), mean arterial pressure from 94±4 to 116±4 mm Hg (P<.05), left ventricular systolic pressure from 116±4 to 151±4 mm Hg (P<.05), left ventricular end-diastolic pressure from 5.5 ±0.5 to 11.5±1.0 mm Hg (P<.05), and left ventricular dP/dtmu from 2770±130 to 6470±590 mm Hg (P<.05) ( Table 1) . Coronary blood flow increased from 51±4 mL/min at rest to 99±7 mL/min at the highest level of exercise (P<.05). Glybenclamide at 10 gg. kg`. min`had no significant effect on any of the systemic hemodynamic variables. However, coronary blood flow was significantly lower at rest and during each level of exercise. Glybenclamide at 50 ,ug. kg.* min1 further decreased coronary blood flow; this was associated with significant elevations of left ventricular end-diastolic pressure at rest and at each level of exercise and a significant reduction of left ventricular dP/dtm.,, at the highest level of exercise.
The reductions in coronary blood flow were not due to glybenclamide-induced decreases in the indices of myocardial oxygen demand. This is illustrated by Fig 4,  in which coronary blood flow has been plotted against heart rate and an index of systolic wall stress. For a given level of heart rate or systolic wall stress index, coronary blood flow was reduced by glybenclamide in a dose-dependent manner. Both doses of glybenclamide resulted in parallel rightward shifts of the relationships between coronary blood flow and both heart rate and the index of systolic wall stress, with no significant change in the slope of these relationships. When of exercise (P<.05), whereas myocardial oxygen consumption increased from 5.7+0.3 to 13.4±0.6 mL 02/ min (P<.05). Glybenclamide caused a slightly greater decrease in coronary blood flow than in myocardial oxygen consumption (Fig 5) , as the glybenclamideinduced flow reductions were accompanied by an increase in oxygen extraction (Fig 6) .
Exercise had no effect on end-diastolic left ventricular wall thickness but increased end-systolic wall thickness in both the left anterior descending coronary artery perfused area (Table 3 ) and the control area (not shown). Consequently, percent systolic wall thickening increased from 21±3% at rest to 31±3% (P<.05) in the area perfused by the left anterior descending coronary artery and from 21±3% to 29±4% (P<.05) in the control area. Glybenclamide had no effect on the enddiastolic wall thickness but decreased end-systolic thickness at rest and during each level of exercise in a dose-dependent manner (Table 3) . Percent systolic wall thickening in the area perfused by the left anterior descending coronary artery was significantly reduced by glybenclamide. The magnitude of the decrease in systolic wall thickening produced by glybenclamide was independent of the exercise level (Table 3, Fig 7) . Glybenclamide had no effect on the response of systolic wall thickening to exercise in the control region perfused by the left circumflex coronary artery (Fig 7) . 
Effect of Vehicle
The effects of the glybenclamide vehicle on the exercise-induced changes in coronary blood flow and systolic wall thickening were studied in five dogs. As shown in Fig 8, the vehicle had no effect on either blood flow or systolic wall thickening in the area perfused by the left anterior descending coronary artery.
Mechanism of Depressed Systolic Function
To determine whether the decrease in systolic wall thickening after glybenclamide resulted from impaired myocardial perfusion, the effect of returning coronary blood flow to the preglybenclamide level was examined during resting condition in three dogs. As shown in Table 4 , during control conditions intracoronary infusion of nitroprusside (10 ,g * kg`* min-') increased coronary blood flow without an effect on systolic wall thickening. Glybenclamide (10 and 50 ,g* kg1 min-m intracoronary) decreased both coronary blood flow and systolic wall thickening. While the infusion of glybenclamide continued, the addition of nitroprusside restored regional function as it increased blood flow. This supports the hypothesis that the glybenclamide-associated decrease of regional contractile function occurred secondary to the reduction in coronary blood flow. , and vehicle at a rate of 1.5 mL/min (a). The vehicle had no effect on either relationship. Discussion This study documents the influence of K+ATP channels on resting coronary blood flow during physiological conditions and the contribution of these channels to the coronary vasodilation that occurs in response to transient myocardial ischemia and to the increased myocardial metabolic demands produced by exercise. Glybenclamide effectively inhibited the coronary vasodilation produced by the K+ATP channel opener pinacidil without altering vascular responsiveness to sodium nitroprusside. Glybenclamide decreased resting coronary blood flow and blunted ischemic vasodilation, decreasing both the magnitude and the duration of reactive hyperemia. However, the exercise-induced increase in coronary blood flow was not attenuated by K+ATP channel blockade. The implications of these findings will be discussed in detail.
In perfused dog hearts, Aversano and colleagues'7 observed that glybenclamide in doses of 0. 8 and 3.7 gmol/min caused a 30% decrease in maximal coronary conductance and a 60% decrease in duration of the reactive hyperemia that followed a 30-second coronary occlusion. Reactive hyperemia excess flow was decreased by 60%. Doses of glybenclamide of 0. 8 and 3.7 ttmol/min administered to 25-to 30-kg dogs correspond to intracoronary infusions of approximately 14.4 and 66.5 gg* kg-min`(molecular weight of glybenclamide, 494), which are comparable to the doses used in the present study. In contrast to the present study, Aversano and colleagues17 found that this dosage range had no effect on basal coronary blood flow in perfused canine hearts. In a preliminary report, Imamura during resting conditions (81±3% during resting conditions in the present study). Although the decrease in coronary blood flow produced by glybenclamide in the study of Samaha and colleagues' failed to cause myocardial oxygen consumption to decrease, the investigators observed conversion from lactate consumption to production, suggesting that oxygen availability to the myocardium was impaired.
In the present study, glybenclamide decreased coronary blood flow at rest. Although myocardial oxygen extraction increased, the high basal level of oxygen extraction prevented full compensation for the decrease in coronary blood flow, resulting in a significant decrease of oxygen delivery. The decreased oxygen availability was associated with contractile dysfunction. In three conscious dogs, we observed that glybenclamideinduced myocardial hypofunction was reversed when coronary blood flow rates were restored to preglybenclamide levels with sodium nitroprusside, confirming earlier observations in anesthetized dogs.19 These findings, together with the observation that potassium channel activators can exert negative inotropic effects,9'20 strongly suggest that the glybenclamide-in- during basal conditions, in the present study glybenclamide caused significant reductions of coronary blood flow in the resting intact animal. Activation of K+ATP channels that occurs in response to brief coronary artery occlusions also cannot be explained by a decrease in cytosolic ATP concentrations. Thus, using 31P nuclear magnetic resonance spectroscopy to measure beat-to-beat changes in high-energy phosphate content, Schwartz and colleagues26 found that myocardial ATP levels did not change during coronary artery occlusions up to 24 seconds in duration. To achieve myocardial ATP levels as low as 1 mM (20% of normal) requires at least 40 minutes of total coronary artery occlusion.27 Several explanations could account for the discrepancies between the in vitro inside-out patch-clamp observations and the present in vivo observations. One possible explanation involves cytosolic compartmentation of ATP; it is possible that changes in local levels of ATP could occur at the cell membrane (and thus in the vicinity of the K+ATP channels) without a measurable change in overall cytosolic ATP levels.
There is evidence to support a relation between local membrane-bound glycolytic ATP production and ion transport across the cell membrane in cardiac myocytes.829 In addition to changes in ATP, ADP levels may participate in regulation of K+ATP channels by shifting the inactivation dose-response curve of ATP to higher concentrations.30 These and other as-yet-unknown mechanisms may be involved in activation of K+ATP channels during resting conditions and during brief periods of ischemia in the intact heart.
Conclusions
Blockade of K+ATP channels decreased resting coronary blood flow and attenuated coronary reactive hyperemia. However, exercise-induced increases in coronary blood flow were not prevented. These data demonstrate that activity of these channels contributes to maintenance of coronary blood flow under resting conditions and facilitates coronary vasodilation in response to a brief ischemic stimulus. However, further opening of K+ATP channels is not essential for the coronary vasodilation that occurs during exercise.
